Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
STARD13
REST API REST API
Homo sapiens
STARD13 is differentially expressed in 224 experiments: 137 organism parts: bone marrow, cerebellum, ... (135 more);, 179 disease states: normal, lung adenocarcinoma, ... (177 more);, 85 cell types 313 cell lines 32 compound treatments and 63 other conditions.
Synonyms GT650, ARHGAP37, DLC2
Orthologs Stard13 (Mus musculus)   STARD13 (1 of 2) (Danio rerio)   STARD13 (Gallus gallus)   Stard13 (Rattus norvegicus)   STARD13 (Bos taurus)   ENSCING00000004038 (Ciona intestinalis)   STARD13 (2 of 2) (Danio rerio)   cv-c (Drosophila melanogaster)   stard13 (Xenopus laevis)   STARD13 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term cytosol, protein binding, cytoplasm, intracellular, membrane, lipid particle, GTPase activator activity, small GTPase mediated signal transduction, regulation of small GTPase mediated signal transduction, mitochondrial membrane, signal transduction, mitochondrion
InterPro Term SAM_2, START_lipid-bd, RhoGAP_dom
UniProt Accession B2R789, Q9Y3M8, B3KT04
Search EB-eye ENSG00000133121
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-17189, E-GEOD-803, E-GEOD-7540, E-GEOD-3526, E-MTAB-62, ... (27 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-5258, E-GEOD-19639, E-GEOD-18005, E-GEOD-19397, E-GEOD-2450, ... (35 experiments)

Factor Value U/D Experiments
LNCaP
2
E-GEOD-14464, E-GEOD-14990
MCF7
2
E-GEOD-5258, E-MTAB-37
K562
2
E-GEOD-24147, E-MTAB-37
MOLT4
2
E-MTAB-37, E-MTAB-62
HL-60
1
2
E-GEOD-5258, E-GEOD-24147, E-MTAB-37
SKMM1
1
E-MTAB-62
307 more value(s).


Cell type

studied in E-GEOD-21668, E-GEOD-3920, E-MEXP-66, E-GEOD-4219, E-GEOD-13909, ... (44 experiments)

Factor Value U/D Experiments
721 B lymphoblast
2
E-AFMX-5, E-TABM-145
induced pluripotent stem cell
2
E-GEOD-18147, E-GEOD-18265
stromal cell
2
E-MEXP-2034, E-GEOD-1460
human embryonic stem cell
1
2
E-GEOD-20033, E-GEOD-18265, E-GEOD-18147
B cell
2
1
E-GEOD-13987
whole blood
1
E-GEOD-3026
79 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-2466, E-MEXP-1121, E-TABM-15, ... (50 experiments)

Factor Value U/D Experiments
lung adenocarcinoma
4
E-GEOD-2514, E-MEXP-231, E-MTAB-62, E-MTAB-37
prostate carcinoma
3
E-GEOD-96, E-MEXP-2034, E-MTAB-62
breast carcinoma
2
E-TABM-276, E-MTAB-37
obesity
2
E-MTAB-62, E-GEOD-2508
Duchenne muscular dystrophy
2
E-GEOD-3307, E-GEOD-1004
breast cancer
2
E-MTAB-62, E-GEOD-22544
173 more value(s).


Compound treatment

studied in E-GEOD-5258, E-GEOD-5741, E-TABM-782, E-GEOD-5824, E-TABM-868, ... (22 experiments)

Factor Value U/D Experiments
none
3
6
E-TABM-868, E-GEOD-5099, E-TABM-782, E-GEOD-412, E-MEXP-1958, ... (9 experiments)
lipopolysaccharide
2
E-TABM-868, E-MEXP-1958
CNOT7+CNOT8
1
E-MEXP-2218
unknown
1
E-GEOD-7307
NaOH
1
E-MEXP-2590
control for heregulin
1
E-GEOD-6462
26 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
E-GEOD-19519
thapsigargin
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519


Biosource provider
studied in E-TABM-325

BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Chromosomal aberration
studied in E-TABM-125

Clinical history
studied in E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-TABM-125, E-GEOD-21589, ... (8 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-MEXP-1251, E-GEOD-21589, ... (7 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-20033, E-GEOD-6236, E-MTAB-62

Disease staging
studied in E-GEOD-19743, E-GEOD-7788, E-TABM-147, E-GEOD-21138, E-GEOD-3013 ... (5 experiments)

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-3494, E-GEOD-6532, E-GEOD-4922, E-GEOD-20194, E-GEOD-16716 ... (5 experiments)

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-16363

family id
studied in E-GEOD-19519

Genetic modification
studied in E-MTAB-73, E-GEOD-20847, E-MEXP-2340, E-MEXP-563

Genotype
studied in E-GEOD-3494, E-GEOD-2466, E-TABM-43, E-TABM-868, E-TABM-601, ... (6 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-13073, E-GEOD-7011, E-MEXP-1446, E-GEOD-9764, E-GEOD-10315, ... (6 experiments)

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-GEOD-21653, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-GEOD-1926, E-MEXP-1648, E-GEOD-19519, ... (23 experiments)

Infection
studied in E-GEOD-12254, E-MEXP-561, E-GEOD-6802

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214

Ki67 ihc
studied in E-GEOD-21653

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-MEXP-455, E-MEXP-958

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Observation
studied in E-TABM-276

Organism
studied in E-GEOD-1801, E-TABM-84

Organism status
studied in E-GEOD-19188

P53 ihc
studied in E-GEOD-21653

Pcr vs rd
studied in E-GEOD-20194, E-GEOD-16716

Phenotype
studied in E-GEOD-21750, E-GEOD-1460

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Protocol type
studied in E-GEOD-3254, E-GEOD-19445, E-GEOD-1343

pt
studied in E-GEOD-21653

RNAi
studied in E-MEXP-2115, E-MEXP-101, E-GEOD-3697, E-MEXP-1857

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743

sbr grade
studied in E-GEOD-21653

Sex
studied in E-GEOD-2466, E-GEOD-7307

Stimulation
studied in E-GEOD-11886, E-GEOD-11428

Strain or line
studied in E-MEXP-1996, E-TABM-125

Survival time
studied in E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-TABM-276

Treatment
studied in E-GEOD-19246, E-GEOD-19136, E-GEOD-15799

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-3494, E-GEOD-6532, E-GEOD-4922

Vehicle
studied in E-GEOD-5258

Processing time: 0.39 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM